Recently visited unit
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
join remind View in APP

Ganli Pharmaceutical (603087.SH)

Questioning stocks
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Ganli Pharmaceutical (sh603087) rating was released in three research reports, and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)

      corporate name:

      Ganli Pharmaceutical Co., Ltd

      Main business:

      R&D, production and sales of recombinant insulin analog APIs and injections.

      Telephone: 010-80593699

      Fax: 010-60504998

      Date of establishment: 1998-06-17

      Listing date: 2020-06-29

      Legal representative: Gan Zhongru

      general manager: Dukai

      Registered capital: 601.202 million yuan

      Issue price: 63.320 yuan

      Latest total share capital: 6012017500 shares

      Latest outstanding shares: 10000 shares

      Segment: Shanghai A-share Shanghai and Shenzhen A-share Shanghai Stock Exchange Index Shangzheng Medicine Shanghai Stock Connect Innovative medicine Pharmaceutical Biology Biological products Pharmaceutical Biology Other biological products Middish Margin trading

      2024-03
      2023-12
      2023-09
      2023-06
      2023-03
      Earnings per share 0.1616 yuan RMB 0.5724 0.4711 yuan 0.2372 yuan 0.0870 yuan
      net asset value per share 18.2486 yuan 18.0801 yuan 17.4853 yuan 17.2276 yuan 17.0519 yuan
      Net operating cash flow per share 0.1368 yuan 0.1842 yuan -0.1360 yuan -RMB 0.1028 -0.0287 yuan
      Return on net assets 0.89% 3.17% 2.69% 1.38% 0.51%
      Undistributed profit per share 11.2159 yuan 11.0543 yuan 11.4912 yuan 11.2572 yuan 11.1071 yuan
      Capital reserve per share 5.6465 yuan 5.6395 yuan 4.5973 yuan 4.5719 yuan 4.5515 yuan
      Date of announcement Allocation scheme
      2024-06-11 10 pairs, 2 yuan
      2022-06-11 10 pies, 3 yuan
      2021-05-15 10 pies, 4 yuan
      2020-08-14 5 yuan for 10 yuan, 4 shares for free
      2024-03
      2023-12
      2023-09
      Name of shareholders Shareholding (%) Increase or decrease
      Gan Zhongru thirty-three point three five four Unchanged
      Beijing Xute Hongda Technology Co., Ltd eight point nine four three Unchanged
      HKSCC has one point three six six Overweight
      Minghua Innovative Technology Investment Co., Ltd one point one eight two reduce one's shares in a listed company
      Ganxiru one point one seven two Unchanged
      Bank of China shares have zero point eight seven one Overweight
      Agricultural Bank of China shares zero point five eight two Overweight
      Zhang Jiazhen zero point four nine zero New progress
      China Merchants Bank Co., Ltd zero point four six four New progress
      As sweet as zero point four one seven Unchanged

      Shareholding ratio of circulating shareholders



      user name:
      Password: